Pathwork Diagnostics developed a genetic test to determine the origin of metatastic cancer tumors. The company faced industry resistance to change as most pathologists preferred diagnosing tissue samples through a microscope. The Tissue of Origin test offered greater accuracy and clear advantages. To overcome industry fear of change, we employed a messaging strategy that focused primarily on difficult to diagnose cases demonstrated in four common scenarios.